Your Genetic Make Up to be Stored, Without Consent, for Profit
By TechEye,
TechEye
| 04. 25. 2013
Dr Helen Wallace, director of GeneWatch UK, warned at a MedConfidential event in London that beyond electronically storing patient records, the next step for the UK is linking these records with DNA and genetic information on an all-in-one database.
It is already public policy, she pointed out, and a Human Genomics Strategy Group (HGSG) urged the need for a national DNA database for personalised medicine last year - which was welcomed by the secretary of state for health, which has asked for the recommendations to be implemented.
Genetic data is massively revealing - and can be used to identify relatives as well as the patient, and can be used to assess the potential for passing recessive genetic disorders on to children.
Anonymisation here, Wallace argued, is impossible. For example, it would be possible to swab DNA from a coffee cup and compare this to your sequence, also linked to your medical record, stored in a research database. The HGSG plan threatens to remove people's right to know exactly who is using their genomic data and why - as...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...